Economic evaluation of interventions for the treatment of asthma in children: A systematic review

Luca Adel Halmai*, Aileen R. Nielson, Mary Kilonzo

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


This systematic review aimed to identify and critique full economic evaluations (EEs) of childhood asthma treatments with the intention to guide researchers and commissioners of pediatric asthma services toward potentially cost‐effective strategies.

“MEDLINE,” “Embase,” “EconLit,” “NHS EED,” and “CEA” databases were searched to identify relevant EEs published between 2005 and May 2017. Quality of included studies was assessed with a published checklist.

Eighteen studies were identified and comprised one cost‐benefit analysis, 11 cost‐effectiveness analyses, one cost‐minimization analysis, and six cost‐utility analyses. Treatments included pharmaceutical (n = 11) and non‐pharmaceutical (n = 7) interventions. Fourteen studies identified cost‐effective strategies. The quality of the studies varied and there were uncertainties due to the methods and relevance of data used.

Good‐quality economic evaluation studies of pediatric asthma treatments are lacking. EE of new technologies adapted to local settings is recommended and can result in cost savings.
Original languageEnglish
Pages (from-to)150-157
Number of pages8
JournalPediatric Allergy and Immunology
Issue number2
Early online date3 Dec 2019
Publication statusPublished - Feb 2020


  • Adverse childhood experience
  • asthma
  • child
  • cost effectiveness
  • cost and cost analysis
  • economic evaluation
  • respiratory tract diseases
  • systematic review


Dive into the research topics of 'Economic evaluation of interventions for the treatment of asthma in children: A systematic review'. Together they form a unique fingerprint.

Cite this